tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market

Circassia Pharmaceuticals (NIOX) Income Statement

Compare
14 Followers

Circassia Pharmaceuticals Income Statement

Last quarter (Q2 2025), Circassia Pharmaceuticals's total revenue was £25.20M, an increase of 34.04% from the same quarter last year. In Q2, Circassia Pharmaceuticals's net income was £5.90M. See Circassia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 41.80M£ 36.80M£ 31.30M£ 27.90M£ 23.90M
Gross Profit
£ 30.20M£ 26.50M£ 22.20M£ 19.00M£ 16.30M
Operating Expenses
£ 22.50M£ 21.90M£ 20.40M£ 23.30M£ 33.60M
Depreciation and Amortization
£ 4.20M£ 4.40M£ 4.60M£ 4.90M£ 9.00M
EBITDA
£ 12.20M£ 8.60M£ 15.20M£ 3.10M£ -9.10M
Operating Income
£ 7.70M£ 4.60M£ 1.80M£ -4.30M£ -17.30M
Other Income/Expenses
£ 100.00K£ -500.00K£ 8.70M£ 2.20M£ -1.10M
Pretax Income
£ 7.80M£ 4.10M£ 10.50M£ -2.10M£ -18.40M
Net Income
£ 3.70M£ 10.70M£ 16.10M£ 3.60M£ -33.50M
Per Share Metrics
Basic EPS
£ 0.01£ 0.03£ 0.04£ 0.01£ -0.09
Diluted EPS
£ 0.01£ 0.02£ 0.04£ 0.01£ -0.09
Weighted Average Shares Outstanding
418.21M 420.20M 419.20M 412.61M 381.86M
Weighted Average Shares Outstanding (Diluted)
448.21M 449.28M 443.00M 435.83M 381.86M
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History